The global market for prosthetic heart valve is forecasted to attain USD 15,294.6 million by 2025, expanding at 7.5% CAGR to reach USD 31,522.6 million by 2035. In 2024, the revenue of prosthetic ...

Similar to testing a car, a team of researchers at UBC Okanagan has been test-driving a number of mechanical heart valves ...

New research by Edwards Lifesciences has demonstrated that early intervention for severe aortic stenosis (AS) before symptoms ...

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Transcatheter aortic valve implantation (TAVI) is an advancing mode of treatment for inoperable or high-risk patients with aortic stenosis. Prosthetic valve endocarditis (PVE) after TAVI is a serious ...

Valve-in-valve transcatheter aortic valve replacement (ViV-TAVR ... measured using preoperative computed tomography for ViV-TAVR. Prosthesis-patient mismatch (PPM) was defined as an indexed effective ...

with the implantation of conventional aortic valve prosthesis and PERCEVAL® (sutureless prosthesis), were analyzed from February 2015 to February 2021. The CPB and aortic cross-clamping times were ...

Background: The importance of moderate patient-prosthesis mismatch (PPM) for the prognosis of patients who undergo aortic valve replacement is unclear. Methods: The presence of PPM was assessed in 361 ...

Aortic valve prosthesis was inserted retrograde using a femoral arterial or a subclavian artery approach. Results In 44 consecutive patients (mean age 79.1±7 years, 50% women, mean left ventricular ...

Standard surgical AVR was defined as primary isolated implantation of a biological or mechanical aortic valve prosthesis. Hence, patients undergoing REDO sternotomy and concomitant procedures such as ...